A new approach to early breast cancer

Breast Cancer, a Heterogeneous Disease Entity: The Very Early Stages

Volumn , Issue , 2011, Pages 1-22

  Tot, Tibor ^a   Kahán, Zsuzsanna ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Early breast cancer; Individualized therapy; Mammographic screening; Prognosis; Prognostic factors

Indexed keywords

EID: 82055186682     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-0489-3_1     Document Type: Chapter

References (116)

1. AJCC Cancer Staging Handbook (2009) TNM classification of malignant tumors, 6th edn. Springer, New York, pp 255-281
2. Alexander MC, Yankaskas BC, Biesemier KW (2006) Association of stellate mammographic pattern with survival in small invasive breast tumors. Am J Roentgenol 187:92-37
3. Andea AA, Bouwman D, Wallis T et al (2004) Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. Cancer 100:20-27
4. Anttinen J, Kautiainen H, Kuopio T (2006) Role of mamography screening as a predictor of survival in postmenopausal breast cancer patients. Br J Cancer 94:147-151
5. Badra FA, Karamouzis MV, Ravazoula P et al (2006) Non-palpable breast carcinomas: Correlation of mammographically detected malignant-Appearing microalcifications and epidermal growth factor receptor (EGFR) family expression. Cancer Lett 244:34-41
6. Bergh J, Holmquist M (2001) Who should not receive adjuvant chemotherapy? J Natl Cancer Inst Monogr 30:103-108
7. Berry DA (2008) The screening mammography paradox: Better when found, perhaps better not to find. Br J Cancer 98:1729-1730
8. Boyages J, Jayasinghe UW, Coombs N (2010) Multifocal breast cancer and survival: Each focus does matter particularly for larger tumors. Eur J Cancer 46:1990-1996
9. Bucchi L, Barchielli A, Ravaioli A et al (2005) Screen-detected vs cilinical breast cancer: The advantage in the relative risk of lymph node metastases decreases with increasing tumour size. Br J Cancer 92:156-161
10. Bucchi L, Foca F, Ravaioli A et al (2009) Receipt of adjuvant systemic therapy among patients with high-risk breast cancer detected by mammography screening. Breast Cancer Res Treat 113:559-566
11. Campbell I, Royle G, Coddington R et al (1993) Management of screen-detected breast cancer. audit of the first 100 cases int he Southampton and Salisbury breast screening programme. Ann R C Surg Engl 73:13-17
12. Carlson RW, Allred DC, Anderson BO et al (2009) Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 7:122-192
13. Carter CL, Allen C, Henson De (1989) Relation of tumor size, lymph node status, and survival in 24, 740 breast cancer cases. Cancer 63:181-187
14. Colleoni M, Rotmensz N, Peruzzotti G et al (2004) Minimal and small size invasive breast cancer with no axillary lymph node involvemen: The need for tailored adjuvant therapies. Ann Oncol 15:1633-1639
15. Coombs NJ, Boyages J (2005) Multifocal and multicentric breast cancer: Does each focus matter? J Clin Oncol 23:7497-7502
16. Cortesi L, Chiuri VE, Ruscelli S et al (2006) Prognosis of screen-detected breast cancers: Results of a population based study. BMC Cancer 6:17
17. Cserni G, Bianchi S, Vezzosi V et al (2007) Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multiinsitutional study. Pathol Oncol Res 13:5-14
18. Curigliano G, Viale G, Bagnardi V et al (2009) Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancer. J Clin Oncol 34:5693-5699
19. Darby S, McGale P, Taylor CW, Peto R (2005) Long-Term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300 000 women in US SEER cancer registries. Lancet Oncol 6:557-565
20. Delaney G, Shafiq J, Chappell G et al (2008) Establishing treatment benchmarks for mammography-screened breast cancer population based on a review of evidence-based clinical guidelines. Cancer 112:1912-1922
21. Dong W, Berry DA, Bevers TB et al (2008) Prognostic role of detection method and its relationship with tumor biomarkers in breast cancer: The university of Texas M.D. Anderson Cancer Center experience. Cancer Epidemiol Biomarkers Prev 17:1096-1103
22. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366:2087-2106
23. Egan RL (1982) Multicentric breast carcinomas: Clinical-radiographic pathologic whole organ studies and 10-year survival. Cancer 49:1123-1130
24. Emami B et al (1999) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109-117
25. Ernst MF, Voogd AC, Coebergh JW et al (2004) Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mamographic screening. Cancer 100:1337-1344
26. Ernster VL, Barclay J, Kerlikowske K et al (2000) Mortality among women with ductal carcinoma in situ of the breast in the population-based Surveillance, Epidemiology and Results Program. Arch Intern Med 160:953-958
27. Evans AJ, Rakha EA, Pinder SE et al (2007) Basal phenotype: A powerful prognostic factor in small screen-detected invasive breast cancer with long-Term follow-up. J Med Screen 14:210-214
28. Fisher B, Dignam J, Tan-Chiu E et al (2001) Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes. J Natl Cancer Inst 93:112-120
29. Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241
30. Forrest AP, Stewart HJ, Everington D (1996) Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 348:708-713
31. Fyles AW, McCready DR, Manchul La et al (2004) Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351:963-970
32. Gallagher HS (1976) Treatment selection in primary breast cancer. Pathologic considerations. Am J Roentgenol 126:135-138
33. Gill PG, Farshid G, Luke CG et al (2004) Detection by screening mammography is a powerful independent predictor of survival in women diagnosed with breast cancer. Breast 13:15-22
34. Gill PG, Luke CG, Roder DM (2006) Clinical and pathological factors predictive of lymph node status in women with screen-detected breast cancer. Breast 15:640-648
35. Glas AM, Floore A, Delahaye LJ et al (2006) Converting a breast cancer microarray signature into a high-Throughput diagnostic test. BMC Genomics 7:278
36. Gluz O, Liedtke C, Gottschalk N et al (2009) Triple-negative breast cancer-current status and future directions. Ann Oncol 20:1913-1927
37. Goldhirsch A, Ingle JN, Gelber RD et al (2009) Thresholds for therapies: Highlights of the St Gallen International Expert Consensus on the Primary therapy of Early Breast Cancer 2009. Ann Oncol 20:1319-1329
38. Gonzales-Angulo AM, Litton JK, Broglio KR et al (2009) High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. J Clin Oncol 27:5700-5706
39. Groenendijk RPR, Horst H, John GMT et al (2002) Critical analysis of the treatment of nonpalpable breast cancer: Toward a less invasive future? World J Surg 26:285-289
40. Hanrahan EO, Valero V, Gonzalez-Angulo AM et al (2006) Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1, T1a, bN0M0): A review of the literature. J Clin Oncol 24:2113-2122
41. Hartmann WH (1984) Minimal breast cancer. An update. Cancer 53(3 Suppl):681-684
42. Henson DE, Chu KC, Levine PH (2003) Histologic grade, stage, and survival in breast carcinoma. Comparison of African American and Caucasian woman. Cancer 98:908-917
43. Hughes KS, Schnaper LA, Berry D et al (2004) Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351:971-977
44. Immonen-Raiha P, Kauhava L, Parvinen I et al (2005) Mammographic screening reduces risk of breast carcinoma recurrence. Cancer 103:474-482
45. James JJ, Evans AJ, Pinder SE et al (2003) Is the presence of mammographic comedo calcification really a prognostic factor for small screen-detected invasive breast cancers? Clin Radiol 58:54-62
46. Joensuu H, Pylkkanen L, Toikkanen S et al (1999) Late mortality from pT1N0M0 breast carcinoma. Cancer 85:2183-2189
47. Joensuu H, Isola J, Lundin M et al (2003) Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: A nationwide population-based study. Clin Cancer Res 9:923-930
48. Joensuu H, Lehtimaki T, Holli K et al (2004) Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA 292:1064-1073
49. Joergensen LE, Gunnarsdottir KA, Lanng C et al (2008) Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996- 2001. Breast 17:587-591
50. Kahán Z, Csenki M, Varga Z et al (2007) The risk of early and late lung sequelae after conformal radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 68:673-681
51. Klemi PJ, Joensuu H, Toikkanen S et al (1992) Aggressiveness of breast cancers found with and without screening. BMJ 304:467-469
52. Klemi PJ, Parvinen I, Pylkkanen L et al (2003) Significant improvement in breast cancer survival through population-based mammography screening. Breast 12:308-313
53. Köster F, Engel JB, Schally AV (2009) Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition. Breast Cancer Res Treat 116:273-279
54. Krzyzanowska MK, Tannock IF (2005) Should screen-detected breast cancers be managed differently? J Natl Cancer Inst 97:1170-1171
55. Kyndi M, Overgaard M, Nielsen HM et al (2009) High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of DBCG 82 b&c. Radiother Oncol 90:74-79
56. Lawrence G, Wallis M, Allgood P et al (2009) Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias. Breast Cancer Res Treat 116:179-185
57. Leitner SP, Swern AS, Weinberger D et al (1995) Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a, b N0 M0). Cancer 76:2266-2274
58. Liljegren G, Lindgren A, Bergh J et al (1997) Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy. Ann Oncol 8:235-241
59. Liljegren G, Holmberg L, Bergh J et al (1999) 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol 17:2326-2333
60. Liu GF, Yang Q, Haffty BG, Moran MS (2009) Clinical-pathological features and long-Term outcomes of tubular carcinoma of the breast compared with invasive ductal carcinoma treated with breast conservation therapy. Int J Radiat Oncol Biol Phys 75:1304-1308
61. Luck AA, Evans AJ, James JJ et al (2008) Breast carcinoma with basal phenotype: Mammographic findings. Am J Roentgenol 191: 346-351
62. MacMillan RD, Purushotham AD, Cordiner C et al (1995) Predicting local recurrence by correlating pre-operative mamographic findings with pathological risk factors in patients with breast cancer. Br J Radiol 68:445-449
63. Malik HZ, Wilkinson L, George WD, Purushotham AD (2000) Preoperative mammographic features predict clinicopathological risk factors for the development of local recurrence in breast cancer. Breast 9:329-333
64. Mannino M, Yarnold JR (2009) Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: Can radiotherapy ever be safely withheld? Radiother Oncol 90:14-22
65. Masood S (1995) Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers. Surg Oncol Clin N Am 4:601-632
66. Molino A, Pavarana M, Micciolo R et al (2000) Comparative study of clinical, pathological and biological characteristics of symptomatic versus asymptomatic breast cancers. Ann Oncol 11:581-586
67. Moody-Ayers SY, Wells CK, Feinstein AR (2000) "Benign" tumors and "early detection" in mamography- screened patients of a natural cohort with breast cancer. Arch Intern Med 160:1109-1115
68. Nealon TF, Nkongho A, Grossi CE et al (1981) Treatment of early cancer of the breast (T1N0M0 and T2N0M0) on the basis of histologic characteristics. Surgery 89:279-289
69. Nguyen PL, Taghian AG, Katz MS et al (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26:2373-2378
70. Offersen BV, Overgaard M, Kroman N, Overgaard J (2009) Accelerated partial breast irradiation as a part of breast conserving therapy of early breast cancer: A systematic review. Radiother Oncol 90:1-13
71. Padmore RF, Fowble B, Hoffman J et al (2000) Microinvasaive breast carcinoma: Clinicopathologic analysis of a single institution experience. Cancer 88:1403-1409
72. Pálka I, Ormándi K, Gaál S et al (2007) Casting-Type calcifications on the mammogram suggest a higher probability of early relapse and death among high-risk breast cancer patients. Acta Oncol 46:1178-1183
73. Pálka I, Kelemen G, Ormándi K et al (2008) Tumor characteristics in screen-detected and symptomatic breast cancers. Pathol Oncol Res 14:161-167
74. Park YH, Kim ST, Cho EZ et al (2010) A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (1 cm) invasive breast cancers: Who might be possible candidates for adjuvant treatment? Breast Cancer Res Treat 119:653-661
75. Peacock C, Given-Wilson RM, Duffy SW (2004) Mammographic casting-Type calcification associated with small screen-detected invasive breast cancers: Is this a reliable prognostic indicator? Clin Radiol 59:165-170
76. Pedersen L, Gunnarsdottir KA, Rassmussen BB et al (2004) The prognostic influence of multifocality in breast cancer patients. Breast 13:188-193
77. Polgár C, Limbergen EV, Pötter R et al (2010) Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO breast cancer working group based on clinical evidence (2009). Radiother Oncol 94: 264-273
78. Pötter R, Gnant M, Kwasny W et al (2007) Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. Int J Radiat Oncol Biol Phys 68: 334-340
79. Rakha EA, Ellis IO, Reis-Filho JS (2008a) Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas). Mod Pathol 21:1060-1061
80. Rakha EA, Reis-Filho JS, Ellis IO (2008b) Impact of basal-like breast carcinoma determination for a more specific therapy. Pathobiol 75:95-103
81. Rosen PP, Groshen S (1990) Factors influencing survival and prognosis in early breast carcinoma (T1N0M0-T1N1M0). Assessment of 644 patients with median follow up of 18 years. Surg Clin North Am 70:937-962
82. Rouzier R, Perou CM, Symmans WF et al (2005) Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11:5678-5685
83. Shen Y, Yang Y, Lurdes, Inoue LY et al (2005) Detection method in predicting breast cancer survival: Analysis of randomized screening trials. J Natl Cancer Inst 97:1195-1203
84. Sihto H, Lundin J, Lehtimaki T et al (2008) Molecular subtypes of breast cancers detected in mammography screening and outside of screening. Clin Cancer Res 14:4103-4110
85. Smart CR, Byrne C, Smith RA et al (1997) Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project. CA Cancer J Clin 47:134-149
86. Smith BD, Arthur DW, Buchholz TA et al (2009) Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74:987-1001
87. Sousa JA, Diener-West M, Gusev Y et al (1998) Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer. Ann Surg Oncol 5:140-149
88. Sparano JA, Hortobágyi GN, Gralow JR et al (2009) Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: Systemic therapy and therapeutic individualization. Breast Cancer Res Treat 120(2):273-284
89. START Trialists' Group, Bentzen SM, Agrawal RK, Aird EG et al (2008a) The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet Oncol 9:331-341
90. START Trialists' Group, Bentzen SM, Agrawal RK, Aird EG et al (2008b) The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet 371(9618):1098-1107
91. Straver ME, Glas AM, Hannemann J et al (2010) The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer. Breast Cancer Res Treat 119:551-558
92. Tabár L, Chen HH, Duffy SW et al (2000) A novel method for perdiction of long-Term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: A prospective study. Lancet 355:429-433
93. Tabár L, Chen HHT, Yen MFA et al (2004) Mammographic tumor features can predict long-Term outcomes reliably in women with 1-14 mm invasive breast carcinoma. Suggestions for the reconsideration of current therapeutic practice and the TNM classification system. Cancer 101:1745-1759
94. Tabár L, Tot T, Dean PB (2007) Breast cancer. Early detection with mammography. Casting type calcifications: Sign of a subtype with deceptive features. Thieme, Stuttgart
95. Tabár L, Dean PB, Chen HHT et al (2010) Early detection of breast cancer challenges current standards of care. In: Silberman H, Silberman AW (eds) Principles and practice of surgical oncology: A multidisciplinary approach to difficult problems. Lippincott Williams and Wilkins, Philadelphia, pp 276-291
96. Tabár L, Dean PB, Tot T et al (2011) The implications of the imaging manifestation of multifocal and diffuse breast cancers. In: Tot T (ed) Breast cancer, a lobar disease. Springer, London, pp 87-152
97. Tavassoli FA (1995) Pathology of advanced primary breast carcinoma. Surg Oncol Clin N Am 4:591-600
98. The Swedish Organized Service Screening Evaluation Group (2006) Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with expanded data. Cancer Epidemiol Biomarkers Prev 15:45-51
99. Thurfjell E, Thurfjell MG, Lindgren A (2001) Mammographic finding as predictor of survival in 1-9 mm invasive breast cancers. Worse prognosis for cases presenting as calcifications alone. Breast Cancer Res Treat 67:177-180
100. Tinterri C, Gatzemeier W, Zanini V et al (2009) Conservative surgery with and without radiotherapy in elderly patients with early-stage breast cancer: A prospective randomised multicentre trial. Breast 18:373-377
101. Tot T (2006) The limited prognostic value of measuring and grading small breast carcinomas: The whole sick lobe versus the details within it. Med Sci Monit 12RA:170-175
102. Tot T (2007) The clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histological sections. Cancer 110:2551-2560
103. Tot T (2009) The metastastic capacity of multifocal breast carcinomas: Extensive tumors versus tumors of limited extent. Hum Pathol 40:199-205
104. Tot T (2010) Towards a renaissance of subgross breast morphology. Eur J Cancer 46:1946-1948
105. Tot T (2006) Radiologic-pathologic correlation of ductal carcinoma in situ of the breast using twoand three-dimensional large histologic sections. Semin Breast Dis 8:144-151
106. Tot T, Pekár Gy, Hofmeyer S et al (2009) The distribution of the lesions in 1-14 mm invasive breast carcinomas and its relation to metastatic potential. Virchows Arch 455:109-115
107. Untch M, Gelber RD, Jackisch C et al (2008) Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial. Ann Oncol 19:1090-1096
108. Veronesi U, Cascinelli N, Mariani L et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227-1232
109. Weissenbacher TM, Zschage M, Janni W et al (2010) Multifocal and multicentric versus unifocal breast cancer: Is the tumor-node-metastasis classification justified? Breast Cancer Res Treat 122:27-43
110. Whelan TJ, Julian J, Wright J et al (2000) Does locoregional radiation therapy improve survival? A meta-Analysis. J Clin Oncol 18:1220-1229
111. Whelan TJ, Kim DH, Sussman J (2008) Clinical experience using hypofractionated radiation schedules in breast cancer. Semin Radiat Oncol 18:257-264
112. Wishart GC, Greenberg DC, Britton PD et al (2008) Screen-detected vs symptomatic breast cancer: Is improved survival due to stage migration alone? Br J Cancer 98:1741-1744
113. Wishart GC, Azzato EM, Greenberg DC et al (2010) PREDICT: A new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Res 12:R1
114. Yarnold J (2009) Early and locally advanced breast cancer: Diagnosis and treatment. National Institute for Health and Clinical Excellence guideline 2009. Clin Oncol (R Coll Radiol) 21:159-160
115. Zafrani B, Vielh P, Fourquet A et al (1989) Conservative treatment of early breast cancer: Prognostic value of the ductal in situ component and other pathological variables on local control and survival. Long-Term results. Eur J Cancer Clin Oncol 25:1645-1650
116. Zunzunegui RG, Chung MA, Oruwari J et al (2003) Casting-Type calcifications with invasion and high-grade ductal carcinoma in situ. Arch Surg 138:537-540